Abstract
The increased vascular calcification, cardiovascular morbidity, and mortality in chronic kidney disease (CKD) patients has been associated with disturbances in mineral-bone metabolism. In order to determine markers of the vascular calcification frequently observed in these patients, blood samples of elderly male and female hemodialysis CKD patients were used to measure serum levels of: osteoprotegerin (OPG), total soluble receptor activator of nuclear factor-κB ligand (sRANKL), and fetuin-A by enzyme immunoassay; tartrate-resistant acid phosphatase (TRACP-5b), and bone-specific alkaline phosphatase (BAP) by immunoenzymometric assay; osteocalcin (OC) by ELISA; iPTH by immunoradiometric assay; 25(OH)D3 and 1,25(OH)2D3, by I125 radioimmunoassay; and calcium and phosphorus by photometric assay. Serum OPG, BAP, iPTH, phosphorus, and OC levels were higher and serum 25(OH)D3, 1,25(OH)2D3, and fetuin-A levels lower in both male and female CKD patients than in their respective controls. Our results indicate that the bone formation and resorption parameters are altered in elderly male and female hemodialysis CKD patients. These changes may lead to vascular calcifications and cardiovascular complications, given that elevated OPG and OC levels and reduced fetuin-A levels are associated with cardiovascular events.
Similar content being viewed by others
References
Locatelli F, Del Vecchio L, Manzoni C (1998) Morbidity and mortality on maintenance haemodialysis. Nephron 80:380–400
Van Kuijk JP, Flu WJ, Chonchol M, Welten GM, Verhagen HJ, Bax JJ, Poldermans D (2010) The prevalence and prognostic implications of polyvascular atherosclerotic disease in patients with chronic kidney disease. Nephrol Dial Transplant 25:1882–1888
Wanner C, Zimmerman J, Quaschning T, Galle J (1997) Inflammation, dyslipidemia and vascular risk factors in hemodialysis patients. Kidney Int 62:S53–S55
Nestel PJ, Fidge NH, Tan MH (1982) Increased lipoprotein-remnant formation in chronic renal failure. New Eng J Med 307:329–333
Kasiske BL (1998) Hyperlipidemia in patients with chronic renal disease. Am J Kidney Dis 32:142–156
Brunzell JD, Albers JJ, Haas LB, Goldberg AP, Agadaa L, Sherrard DJ (1997) Prevalence of serum lipid abnormalities in chronic hemodialysis. Metabolism 26:903–907
Senti M, Romero R, Pedro-Botert J, Pelegri A, Nogues X, Rubies-Part J (1992) Lipoprotein abnormalities in hyperlipidemic and normolipidemic men on hemodialysis with chronic renal failure. Kidney Int 41:1394–1399
Pawlak K, Pawlak D, Mysliwiec M (2004) Oxidative stress influences CC-Chemokine levels in hemodialyzed patients. Nephron Physiol 96:105–112
Massy ZA, Nguyen-Khoa T (2002) Oxidative stress and chronic renal failure: markers and management. J Nephrol 15:336–341
Junguers P, Massy ZA, Khoa TN, Fumeron C, Labrunie M, Lacour B, Descamps-Latscha BM (1997) Incidence and risk factors of atherosclerotic cardiovascular accidents in predialysis chronic renal failure patients: a prospective study. Nephrol Dial Transplant 12:2597–2602
Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K (2000) Morphology of coronary atherosclerotic cardiovascular accidents lesions in patients with end-stage renal-failure. Nephrol Dial Transplant 15:218–223
Dellegrottaglie S, Sanz J, Rajagopalan S (2006) Vascular calcification in patients with chronic kidney disease. Blood Purif 24:56–62
Kestenbaum B, Belozeroff V (2007) Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest 37:607–622
Bostrom K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL (1993) Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 91:1800–1809
Fitzpatrick LA, Severson A, Edwards WD, Imgram RT (1994) Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 94:1597–1604
Moe SM, O’Neill KD, Duan D, Ahmed S, Chem NX, Leapman SB, Fineberg N, Kopecky K (2002) Medical artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int 61:638–647
Abbadi M, Giachelli CM (2007) Mechanism of vascular calcification. Adv Chrononic Kidney Dis 14:54–66
Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL (1994) High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393–2402
Ix JH, Shlipak MG, Sarnak MJ, Beck GJ, Greene T, Wang X, Kusek JW, Collins AJ, Levey AS, Menon V (2007) Fetuin-A is not associated with mortality in chronic kidney disease. Kidney Int 72:1394–1399
Osorio A, Ortega E, de Haro T, Torres JM, Sanchez P, Ruiz-Requena E (2011) Lipids profiles and oxidative stress parameters in male and female hemodialysis patients. Mol Cell Biochem 353:59–63
Jono S, Shioi A, Ikari Y, Nishizawa Y (2006) Vascular calcification in chronic kidney disease. J Bone Miner Metab 24:176–181
Shroff R, Egerton M, Bridel M, Shah V, Donald AE, Cole TJ, Hiorns MP, Deanfield JE, Rees L (2008) A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 19:1239–1246
Michaud J, Naud J, Ouimet D, Demers C, Petit JL, Leblond FA, Bonnardeaux A, Gascon-Barré M, Pichette V (2010) Reduced hepatic synthesis of calcidiol in uremia. J Am Soc Nephrol 21:1488–1497
Taskapan H, Wei M, Oreopoulos DG (2006) 25(OH) Vitamin D3 in patients with chronic kidney disease and those on dialysis: rediscovering its importance. Int Urol Nephrol 38:323–329
Ghazali A, Fardellone P, Pruna A, Atik A, Achard JM, Oprisiu R, Brazier M, Remond A, Moriniére P, Garabedian M, Eastwood J, Fournier A (1999) Is low plasma 25-(OH) vitamin D a major risk factor for hyperparathyroidism and Looser’s zones independent of calcitriol? Kidney Int 55:2169–2177
Shioi A, Katagi M, Okuno Y, Mori K, Jono S, Koyama H, Nishizawa Y (2002) Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 91:9–16
Sigrist MK, Levin A, McIntyre CW (2009) Elevated osteoprotegerin is associated with all-cause mortality in CKD stage 4 and 5 patients in addition to vascular calcification. Nephrol Dial Transplant 24:3157–3162
Doumouchtsis KK, Kostakis AI, Doumouchtsis SK, Tziamalis MP, Tsigris C, Kostaki MA, Perrea DN (2007) sRANKL/osteoprotegerin complex and biochemical markers in a cohort of male and female hemodialysis patients. J Endocrinol Invest 30:762–766
Osorio A, Ortega E, Torres JM, Sanchez P, Ruiz-Requena E (2011) Mineral-bone metabolism markers in young hemodialysis patients. Clin Biochem 44:1425–1428
Nitta K, Akiba T, Uchida K, Kawashima A, Yumura W, Kabaya T, Nihei H (2003) The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term hemodialysis. Am J Kidney Dis 42:303–309
Avbersek-Luznik I, Balon BP, Rus I, Marc J (2005) Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant 20:566–570
Klejna K, Naumnik B, Gasowska K, Mysliwiec M (2009) OPG/RANK/RANKL signaling system and its significance in nephrology. Folia Histochem Cytobiol 47:199–206
Hofbauer LC, Schoppet M (2001) Osteoprotegerin: a link between osteoporosis and arterial calcification? Lancet 358:257–259
Panizo S, Cardus A, Encinas M, Parisi E, Valcheva P, López-Ongil S, Coll B, Fernandez E, Valdivielso JM (2009) RANKL increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 104:1041–1048
Van Campenhout A, Golledge J (2009) Osteoprotegerin, vascular calcification and atherosclerosis. Atherosclerosis 204:321–329
Montecucco F, Steffens S, Mach F (2007) The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? Clin Dev Immunol 2007:75805
Ketteler M, Bongartz P, Westenfeld R, Jahnen-Dechent W, Ketteler M (2003) Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 361:827–833
Idelevich A, Rais Y, Monsonego-Ornan E (2011) Bone Gla protein increases HIF-1α-dependent glucose metabolism and induces cartilage and vascular calcification. Arterioscler Thromb Vasc Biol 31:55–71
Acknowledgments
The authors thank Magdalena Quintana for technical assistance and Richard Davies for revising the English text. This study was funded in part by grant CICYT/FEDER (BFU2008-06843) and by the Andalusian Regional Government (Endocrinology & Metabolism Group).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Osorio, A., Ortega, E., Torres, J.M. et al. Biochemical markers of vascular calcification in elderly hemodialysis patients. Mol Cell Biochem 374, 21–27 (2013). https://doi.org/10.1007/s11010-012-1500-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-012-1500-y